Skip to main content
Industry News
AI framework may help repurpose drugs for AD

Researchers developed an artificial intelligence-based framework that could offer a fast and cost-effective way to repurpose drugs as treatments for Alzheimer's disease, according to a report in Nature Communications. The Drug Repurposing in Alzheimer's Disease, or DRIAD, also may help scientists analyze proteins that are targeted by Alzheimer's treatments with the most potential, and whether there are common trends in these targets.

Full Story: